Technical Analysis for NVYTF - Novacyt

Grade Last Price % Change Price Change
grade A 2.63 0.00% 0.0000
NVYTF closed unchanged on Tuesday, April 7, 2020, on 85 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Up
Historical NVYTF trend table...

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Older signals for NVYTF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Novacyt S.A., together with its subsidiaries, engages in developing, manufacturing, and commercializing clinical diagnostic products for cancer and infectious diseases in Africa, Europe, the Asia Pacific, the United States, and the Middle East. The company operates through Corporate and Diagnostics and Molecular Testing segments. The Corporate and Diagnostics segment manufactures and distributes reagents and kits for bacterial and blood tests. The Molecular Testing segment designs, manufactures and distributes test kits for certain diseases in humans, animals, and food products. The company's diagnostic products are used in oncology, microbiology, haematology, and serology testing. It also develops, manufactures, and distributes diagnostic products for food laboratories; and manufactures and supplies reagents, as well as tests for in vitro diagnostic tests and blood grouping application, under the Plasmatec and Biotec brand names. It serves universities, hospitals, clinics, and testing laboratories. The company was founded in 2006 and is based in Camberley, the United Kingdom.
Cancer Food Products Infectious Diseases Diagnostic Tests Medical Tests Diagnostic Products Certain Diseases Diagnostic Ortho Clinical Diagnostics

Is NVYTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.9
52 Week Low 0.87
Average Volume 16,233
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 1.8560
10-Day Moving Average 2.2000
Average True Range 0.2599
ADX 25.22
+DI 55.5996
-DI 26.0946
Chandelier Exit (Long, 3 ATRs ) 1.8503
Chandelier Exit (Short, 3 ATRs ) 1.9297
Upper Bollinger Band 2.6914
Lower Bollinger Band 1.0206
Percent B (%b) 0.96
BandWidth 90.0216
MACD Line 0.2697
MACD Signal Line 0.1815
MACD Histogram 0.0882
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.6900
Resistance 3 (R3) 2.6833 2.6567 2.6800
Resistance 2 (R2) 2.6567 2.6414 2.6600 2.6767
Resistance 1 (R1) 2.6433 2.6319 2.6500 2.6500 2.6733
Pivot Point 2.6167 2.6167 2.6200 2.6200 2.6167
Support 1 (S1) 2.6033 2.6014 2.6100 2.6100 2.5867
Support 2 (S2) 2.5767 2.5919 2.5800 2.5833
Support 3 (S3) 2.5633 2.5767 2.5800
Support 4 (S4) 2.5700